WIHI: The How and Why of Deprescribing

Date: September 13, 2018


  • Nicole Brandt, PharmD, MBA, BCGP, BCPP, FASCP, Executive Director, Peter Lamy Center on Drug Therapy and Aging; Professor, University of Maryland School of Pharmacy 
  • Florian Daragjati, PharmD, BCPS, Director, Ascension Center of Excellence for Antimicrobial Stewardship and Infection Prevention
  • Lynn Deguzman, PharmD, BCGP, Regional Clinical Operations Manager, Kaiser Permanente
  • Leslie J. Pelton, MPA, Senior Director, Institute for Healthcare Improvement
  • Leanne Phillips, PharmD, BCPS, Clinical Pharmacy Coordinator, St. Vincent’s East, Ascension

The ground is shifting for prescription medication in the US and Canada, and in other countries, too. There’s much talk and publicity about weaning people off drugs, or what is referred to as “deprescribing”: a process that entails taking patients off some of their medications or tapering down the dosages.

The underlying reasons for deprescribing include concerns about polypharmacy, especially the impact on older and frail adults; antibiotic resistance caused by inappropriate and excessive use; and the ongoing opioid epidemic connected to years of overprescribing highly addictive medicines for pain.

A growing number of health care organizations are working with IHI on how to safely implement deprescribing. Learn about their experiences and the future of this work on this episode of WIHI.


Average Content Rating
(2 users)
Please login to rate or comment on this content.
User Comments